chartexchange

CALC
CalciMedica, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:17 PM EDT
1.62USD-2.121%(-0.03)21,833
Loading…
Loading…
Healthcare
Biotechnology
HQ
La Jolla, CA, USA
Previous Close
$1.65
Beta
0.59
52-Week High
$36.00 2026-01-02
52-Week Low
$1.58 2026-10-02
SMA 50
$2.67
SMA 200
$6.81
Avg. Vol 10D
46,969
Avg. Vol 30D
83,274
Avg. Vol 90D
212,808
Relative Vol
0.26
3.46M
99.1400%
Nov 11, 2026 (37d)
Aug 31, 2026 · 1-for-5 (reverse)
CALC Profile

calcimedica is dedicated to the discovery and development of novel small molecule drugs for the treatment of autoimmune disorders, organ transplant rejection, and other immune diseases.

CALC Performance
PeriodPriceDateChangeBeta
1W1.682026-09-28-2.38%-1.106
1M2.172026-09-04-24.42%-0.431
3M4.942026-07-06-66.80%1.342
6M3.122026-04-06-47.44%0.231
1Y16.002025-10-03-89.75%0.594
2Y21.792024-10-04-92.47%—
5Y31.652023-03-21-94.82%0.011
CALC Stock Summary

CalciMedica, Inc. Common Stock (NASDAQ:CALC) stock price today is $1.64, and today's volume is 21,833. CALC is down 0.606% today. The 30 day average volume is 83,274. CALC market cap is $11.20M with 6.83M shares outstanding.